Although the expression of obestatin was described in human gastric neuroendocrine tumors [9, 10], no studies have provided evidence of the obestatin/GPR39 expression in other types of gastric cancer, especially adenocarcinomas, or the functional role of this system in these cancers. This evidence concerns the gene GHRL and cancer.